According to the prognostic model proposed in Figure 3A, lower-grade gliomas were categorized into nine subgroups based on the status of IDH and TERT promoter mutations, 1p/19q codeletion, and NLR. The gene discussed is IDH2; the disease is central nervous system cancer.